Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New surveillance data from the Vaccine Adverse Event Reporting System (VAERS) back previous ...
FDA warns of an increased risk of Guillain-Barré Syndrome following vaccination with the J&J vaccine
The Food and Drug Administration today revised the Janssen COVID-19 vaccine fact sheet for healthcare providers to include a warning of an observed increased risk of Guillain-Barré Syndrome following ...
AMSTERDAM, Aug 23 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and ...
More than six months after Johnson & Johnson merged its infectious disease and vaccine units, the healthcare giant is cutting research and development for the unit altogether, according to sources ...
The Food and Drug Administration has withdrawn authorization for Johnson & Johnson’s COVID-19 vaccine, ending its short-lived but troubled existence amid the pandemic. In a letter last week, the FDA’s ...
Drugmaker Johnson + Johnson said Monday it has paused the advanced clinical trial of its experimental coronavirus vaccine because of an unexplained illness in one of the volunteers. "Following our ...
Credit: Getty Images. The last lots of the vaccine purchased by the US government have expired. The Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) of the Janssen ...
LEIDEN, the Netherlands--(BUSINESS WIRE)--Cancer vaccine company DCPrime BV today announced that it has entered into a research and optional license agreement with Janssen Pharmaceuticals, Inc. The ...
Sanofi on Tuesday announced it had reached an agreement with Janssen, a part of Johnson & Johnson, to develop and commercialize a vaccine candidate for extra-intestinal pathogenic E.coli. Under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback